Anaplastic Large Cell Lymphoma Completed Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Lymphomas, Anaplastic Large-Cell / Anaplastic large-cell lymphoma / Large cell (Ki-1+) lymphoma / Lymphoma, Large-Cell, Anaplastic / Anaplastic large cell lymphoma, CD30-positive

DBCOND0028602 (Anaplastic Large Cell Lymphoma)Completed1 IdentifierTitlePurposeDrugs
NCT00458731Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaTreatment